Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Elite Laboratories, Inc.”

7 pharma patents match "Elite Laboratories, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Elite Laboratories, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Elite Laboratories, Inc.” · 30,257 patents in full index Clear search

  1. US 10213388

    Abuse resistant oral dosage forms

    Elite Laboratories, Inc. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  2. US 9056054

    Abuse resistant oral dosage forms

    Elite Laboratories, Inc. · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  3. US 8703186

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  4. US 8425933

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  5. US 8182836

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

  6. US 6984402

    Chrono delivery formulations and method of treating atrial fibrillation

    Elite Laboratories, Inc. · Granted Jan 10, 2006 · Expires Jan 5, 2026

    expired

  7. US 6926909

    Chrono delivery formulations and method of use thereof

    Elite Laboratories, Inc. · Granted Aug 9, 2005 · Expires Aug 4, 2025

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.